Herpes News and Research

GSK to discontinue development of Herpes Vaccine

GlaxoSmithKline provides update on Herpevac trial for women evaluating Simplirix™ and at this point in time will not further pursue the development of this experimental herpes vaccine.

http://www.gsk.com/media/pressreleases/2010/2010_pressrelease_10105.htm

Study Finds Genital Herpes Vaccine Ineffective in Women

(Herpevac trial)

http://www.niaid.nih.gov/news/newsreleases/2010/Pages/Herpevac.aspx

U.S. herpes rates remain high – CDC

http://www.reuters.com/article/idUSN0923528620100309